Live Cell Multiplex Assay
Dawn of a New Era for Kinase Drug Discovery: Kinome Wide Profiling and Screening Solutions Coupled to Functional Cell-based Assays Enable Launch of Selective and Functional Kinase Inhibitors
Use of a Label-Free Platform in a preclinical Contract Research Organization Environment
Integrating Process Weighing Data
Carbonylation using carbon monoxide: Novasep’s shortcut to complex structures
Bile Acids: Beyond Cholesterol Metabolism & Fat Absorption
The New Role of Academia in Drug Discovery and Development: New Thinking, New Competencies, New Results
Five leaders in the medical innovation field released a white paper today titled The New Role of Academia in Drug Discovery and Development: New Thinking, New Competencies, New Results. This white paper reflects key recommendations from a July 2010 town hall meeting in Kansas City.
The ROI of Contract Research Services
NonClinical Dose Formulation Analysis Method Validation and Sample Analysis
Nonclinical Dose Formulation Analysis Method Validation and Sample Analysis, addresses the fact that no regulatory guidances exist for either nonclincal dose formulation analysis (NCDFA) or for sample analysis. The only current regulatory guidance is the bioanalytical guidance for method validation.